Brought to you by 
OctoPlus and Diatos ally on delivery platform
28 Jul 2003
Executive Summary
Drug delivery biotechs Diatos SA and OctoPlus Technologies BV will try to develop a universal platform for targeted intracellular delivery of biological molecules. The five-year project, titled Transpepdex, has won Euro2.5mm ($2.48mm) in Eureka grants from the Dutch and French governments.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Macromolecule
-
Drug Delivery
-
Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
OctoPlus and Diatos ally on delivery platform
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice